RELX ORD 14 51/116P – Consensus Indicates Potential -8.5% Downside

Broker Ratings

RELX ORD 14 51/116P found using the EPIC (LON:REL) now have 16 analysts in total covering the company. The range between the high target price and low target price is between £20.50 and £11.5 so the average target price would be £17.39. Given that the previous closing share price was at £18.99 this now indicates there is a potential downside of -8.5%. The 50 day moving average now sits at £17.66 while the 200 day moving average is £17.63. The market capitalisation for the company is £37b. You can visit the company’s website by visiting:

RELX provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Scientific, Technical & Medical; Risk; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as enhance the productivity. The Exhibitions segment is involved in the events business. The company was formerly known as Reed Elsevier and changed its name to RELX in July 2015. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.

Good news travels fast (but only if you make that happen):

Share on twitter
Share on linkedin
Share on facebook
Share on email
Share on whatsapp

AIM All Share Index